Several studies have shown that short-term treatment with GLP-1 RAs, either as monotherapy or in combination with metformin, produces significant weight loss and favorable metabolic changes in women with overweight or obesity and PCOS. This evidence concerns the gene GLP1R and obesity due to melanocortin 4 receptor deficiency.